Medications ›almotriptan

almotriptan

RxCUI 279645 ingredient

Contraindicated with · 37

Diagnoses21

Coronary Vasospasm Cluster Headache Trigeminal Autonomic Cephalalgias Migraine with Aura Ischemic Attack, Transient Angina Pectoris, Variant Brain Ischemia Angina, Unstable Headache Disorders, Primary Stroke Angina Pectoris Chest Pain Coronary Disease Myocardial Infarction Infarction Ischemia Necrosis Hypertension Myocardial Ischemia Pain Drug Hypersensitivity

Condition families16

Migraine Disorders Headache Disorders Peripheral Vascular Diseases Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Heart Diseases Neurologic Manifestations Vascular Diseases Nervous System Diseases Cardiovascular Diseases Signs and Symptoms Pathologic Processes Pathological Conditions, Signs and Symptoms Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 6

Diagnoses1

Headache Disorders, Primary

Condition families5

Migraine Disorders Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.